D. Berzow

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.

F. Tacke, B. Paulweber, M. Muche, 2022, Journal of hepatology.

HIV-2: A summary of present standard of care and treatment options for HIV-2 infected individuals living in Western Europe.

C. Charpentier, R. Kaiser, J. Rockstroh, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Immunodeficiency Virus–2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe

C. Charpentier, R. Kaiser, J. Rockstroh, 2020, Clinical Infectious Diseases.

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany

M. Bickel, S. Mauss, H. Heiken, 2022, Infection.

Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern—A first case‐series experience

M. Aepfelbacher, M. Addo, A. Lohse, 2022, Journal of medical virology.

Complement‐mediated enhancement of HIV‐1 infection of the monoblastoid cell line U937

H. Lehr, M. Dierich, H. Wachter, 1990, AIDS.

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

M. Muche, K. Gadow, D. Semela, 2024, JHEP Reports.